ASPARTYLGLYCOSAMINURIA - PROTEIN CHEMISTRY AND MOLECULAR-BIOLOGY OF THE MOST COMMON LYSOSOMAL STORAGE DISORDER OF GLYCOPROTEIN DEGRADATION

被引:52
作者
MONONEN, I
FISHER, KJ
KAARTINEN, V
ARONSON, NN
机构
[1] UNIV KUOPIO,DEPT CLIN CHEM,SF-70210 KUOPIO,FINLAND
[2] AI VIRTANEN INST,CTR DIAGNOST BIOTECHNOL,SF-70210 KUOPIO,FINLAND
[3] WISTAR INST ANAT & BIOL,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104
[4] CHILDRENS HOSP LOS ANGELES,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90054
[5] UNIV SO ALABAMA,DEPT BIOCHEM,MOBILE,AL 36688
关键词
ASPARTYLGLYCOSAMINURIA; ASPARTYLGLUCOSAMINIDASE; ASPARTYLGLUCOSAMINURIA; GLYCOSYLASPARAGINASE; ASPARAGINASE; MECHANISM OF ACTION; GLYCOPROTEIN DEGRADATION; MOLECULAR BIOLOGY; DNA DIAGNOSTICS; LYSOSOMES; GENETICS;
D O I
10.1096/fasebj.7.13.8405810
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aspartylglycosaminuria (AGU) (McKusick 20840) is the most common disorder of glycoprotein degradation caused by the failure of lysosomes to digest the protein-to-carbohydrate linkage of Asn-linked glycoproteins. During the past few years there has been significant progress in our understanding of both the protein chemistry and molecular biology of glycosylasparaginase (EC 3.5.1.26) as well as the molecular changes underlying the storage disease AGU that results from deficiency of this lysosomal hydrolase. Modern clinical assays have been developed for the diagnosis and carrier detection of this disease. Detailed structure, substrate specificity, mechanism of action, and a part of the active site of glycosylasparaginase have been defined. Molecular biology of glycosylasparaginase has progressed rapidly and already some mutations in the glycosylasparaginase gene resulting in AGU have been identified. Evolutionary aspects based on sequence data indicate a mechanistic relationship between mammalian glycosylasparaginases and bacterial/plant asparaginases.
引用
收藏
页码:1247 / 1256
页数:10
相关论文
共 95 条
  • [21] FISHER KJ, 1991, J BIOL CHEM, V266, P12105
  • [22] DELETION OF EXON-8 CAUSES GLYCOSYLASPARAGINASE DEFICIENCY IN AN AFRICAN-AMERICAN ASPARTYLGLUCOSAMINURIA (AGU) PATIENT
    FISHER, KJ
    ARONSON, NN
    [J]. FEBS LETTERS, 1991, 288 (1-2) : 173 - 178
  • [23] GEHLER J, 1981, HELV PAEDIATR ACTA, V36, P179
  • [24] HUMAN-LEUKOCYTE ASPARTYLGLUCOSAMINIDASE - EVIDENCE FOR 2 DIFFERENT SUBUNITS IN A MORE COMPLEX NATIVE STRUCTURE
    HALILA, R
    BAUMANN, M
    IKONEN, E
    ENOMAA, N
    PELTONEN, L
    [J]. BIOCHEMICAL JOURNAL, 1991, 276 : 251 - 256
  • [25] 5-DIAZO-4-OXO-L-NORVALINE - REACTIVE ASPARAGINE ANALOG WITH BIOLOGICAL SPECIFICITY
    HANDSCHUMACHER, RE
    BATES, CJ
    CHANG, PK
    ANDREWS, AT
    FISCHER, GA
    [J]. SCIENCE, 1968, 161 (3836) : 62 - +
  • [26] ASPARTYLGLYCOSAMINURIA PRESENTING WITH HEPATOSPLENOMEGALY IN EARLY INFANCY
    HAWORTH, JC
    SEARGEANT, LE
    DILLING, LA
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (06) : 933 - 934
  • [27] AMINO-ACID SEQUENCE OF DIAZOOXONOR-LEUCINE BINDING-SITE OF ACINETOBACTER AND PSEUDOMONAS-7A GLUTAMINASE-ASPARAGINASE ENZYMES
    HOLCENBERG, JS
    ERICSSON, L
    ROBERTS, J
    [J]. BIOCHEMISTRY, 1978, 17 (03) : 411 - 417
  • [28] HREIDARSSON S, 1983, CLIN GENET, V23, P427
  • [29] LYSOSOMAL ASPARTYLGLUCOSAMINIDASE IS PROCESSED TO THE ACTIVE SUBUNIT COMPLEX IN THE ENDOPLASMIC-RETICULUM
    IKONEN, E
    JULKUNEN, I
    TOLLERSRUD, OK
    KALKKINEN, N
    PELTONEN, L
    [J]. EMBO JOURNAL, 1993, 12 (01) : 295 - 302
  • [30] ASPARTYLGLUCOSAMINURIA - CDNA-ENCODING HUMAN ASPARTYLGLUCOSAMINIDASE AND THE MISSENSE MUTATION CAUSING THE DISEASE
    IKONEN, E
    BAUMANN, M
    GRON, K
    SYVANEN, AC
    ENOMAA, N
    HALILA, R
    AULA, P
    PELTONEN, L
    [J]. EMBO JOURNAL, 1991, 10 (01) : 51 - 58